Goldman Sachs’s Vigil Neuroscience VIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-42,562
Closed -$338K 6668
2025
Q2
$338K Sell
42,562
-13,004
-23% -$58.3K ﹤0.01% 5377
2025
Q1
$98.9K Sell
55,566
-201,076
-78% -$451K ﹤0.01% 5786
2024
Q4
$436K Buy
+256,642
New +$758K ﹤0.01% 5326
2024
Q3
Sell
-401,139
Closed -$1.6M 6090
2024
Q2
$1.6M Buy
401,139
+382,900
+2,099% +$1.31M ﹤0.01% 4083
2024
Q1
$62.2K Sell
18,239
-66,861
-79% -$209K ﹤0.01% 5301
2023
Q4
$288K Sell
85,100
-61,102
-42% -$314K ﹤0.01% 5027
2023
Q3
$788K Buy
146,202
+133,194
+1,024% +$920K ﹤0.01% 4411
2023
Q2
$122K Sell
13,008
-11,818
-48% -$112K ﹤0.01% 5323
2023
Q1
$243K Sell
24,826
-48,185
-66% -$542K ﹤0.01% 5216
2022
Q4
$913K Sell
73,011
-13
-0% -$160 ﹤0.01% 4478
2022
Q3
$665K Sell
73,024
-53
-0.1% -$389 ﹤0.01% 4787
2022
Q2
$189K Sell
73,077
-762
-1% -$3.01K ﹤0.01% 5664
2022
Q1
$519K Buy
+73,839
New +$974K ﹤0.01% 5293

Other funds holding VIGL